Merck flexes muscle with GTx deal
Merck & Co has inked a deal potentially worth over $507m (€346m) with GTx over a new class of drugs to treat muscle loss conditions, especially those caused by cancer.
Archives for November 7, 2007
New counterfeit report highlights worrying trends
A new report highlights a number of worrying trends emerging in regard to the increasing number of fake pharmaceuticals infiltrating supply chains around the globe.
New oral film takes the heat out of manufacturing
Another oral dissolvable film has been developed, with the formulation and manufacturing process potentially giving the strip a production advantage.
New firm to tackle poor solubility head on
A new Belgian company has joined the throng of pharmas tapping into the booming drug delivery business, but claims that its unique technologies will carve it a place as one of the industry's key players.